Amylin Pharmaceuticals, Inc. (NASDAQ:AMLN) Investor files Lawsuit against Directors over alleged Wrongdoing
A lawsuit was filed by a current investor in NASDAQ:AMLN over alleged breaches of fiduciary duties by certain directors of Amylin Pharmaceuticals, Inc. and other current long-term NASDAQ:AMLN stockholders should contact the Shareholders Foundation.
View full press release